1.Norman, RMG, Malla, KA. Duration of untreated psychosis: a critical evaluation of the concept and its importance. Psychol Med 2001; 31: 381–400.
2.Skeate, A, Jackson, C, Birchwood, M, Jones, C. Duration of untreated psychosis and pathways to care in first episode psychosis: investigation of help seeking behaviour in primary care. Br J Psychiatry (Suppl) 2002; 181(43): S73–S77.
3.Browne, S, Clarke, M, Gervin, M, Waddington, JL, Larkin, C, O'Callaghan, E. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000;176:173–6.
4.Harris, MGet al.The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res 2005; 79: 85–93.
5.Keshavan, MS, Berger, G, Zipursky, RB, Wood, SJ, Pantelis, C. Neurobiology of early psychosis. Br J Psychiatry (Suppl) 2005; 187: S8–S18.
6.Wyatt, R. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia. Schizophr Res 1991; 5: 201–2.
7.Harrop, CE, Trower, P. Why does schizophrenia develop at late adolescence? Chichester: Wiley, 2003.
8.Heinrichs, RW, Zakzanis, KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12: 426–45.
9.Byrne, Met al.Neuropsychology, genetic liability and psychotic symptoms in those at high risk of schizophrenia. J Abnorm Psychol 2002; 112: 38–48.
10.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed). Washington DC: American Psychiatric Association, 1994.
11.Beiser, M, Erickson, D, Fleming, JAE, Iacono, WG. Establishing the onset of psychotic illness. Am J Psychiatry 1993; 150: 1349–54.
12.Andreasen, NC. The scale for the assessment of positive symptoms (SAPS). Iowa City: University of Iowa, 1983b.
13.Andreasen, NC. The scale for the assessment of negative symptoms (SANS). Iowa City: University of Iowa, 1983a.
14.Malla, AK, Norman, RM, Manchada, R. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med 2002; 32: 1109–19.
15.Thorup, Aet al.Integrated treatment ameliorates negative symptoms in first episode psychosis – results from the Danish OPUS trial. Schizophr Res 2005; 79: 95–105.
16.Taylor, D, Patton, C, Kerwin, R. The South London and Maudsley NHS Trust Prescribing Guidelines (7th ed). Martin Dunitz: London, 2003.
17.ORYGEN Early Psychosis Service. First Episode Psychosis Survey Guidelines. Personal Communication. Melbourne, 2005
18.Wechsler, D. Wechsler Adult Intelligence Scale (3rd ed). New York: Psychological Corporation, 1997a.
19.Wechsler, D. Wechsler Test of Adult Reading. New York: Psychological Corporation, 2001.
20.Conners, CK. CPT: Connors' Continuous Performance Test. Toronto: Multi-Health Systems, 1995.
21.Spreen, O, Strauss, E. A compendium of neuropsychological tests: administration, norms and commentary. London: Oxford University Press, 1991.
22.Lezack, MD. Neuropsychological Assessment. New York: Oxford University Press, 1995.
23.Wilson, BA, Alderman, N, Burgess, PW, Emslie, H, Evans, JJ. Behavioural Assessment of the Dysexecutive Syndrome. St Edmunds, UK: Thames Valley Test Company, 1996.
24.Wechsler, D. The measurement and appraisal of adult intelligence. Baltimore: Williams and Wilkins Company, 1958.
25.Amminger, GP, Edwards, J, McGorry, PD. Estimating cognitive deterioration in schizophrenia. Br J Psychiatry 2002; 181: 164.
26.Russsell, AJ, Munro, J, Jones, PB, Hayward, P, Hemsely, DR, Murray, RM. The National Adult Reading Test as a measure of premorbid IQ in schizophrenia. Br J Clin Psychol 2000; 39: 297–305
27.Bilder, RM, Mukherjee, S, Rieder, RO, Pandurangi, AK. Symptomatic and neuropsychological components of defect states. Schizophr Bull 1985; 11: 409–19
28.Norman, RMG, Townsend, L, Malla, AK. Duration of untreated psychosis and cognitive functioning in first episode patients. Br J Psychiatry 2001; 179: 340–5.
29.Friss, Set al.Effects of an early detection program on duration of untreated psychosis: part of the Scandinavian TIPS study. Br J Psychiatry (Suppl) 2005; 48: S29–S32.
30.Woodward, ND, Purdon, SE, Meitzer, HY, Zald, DH. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharm 2005; 8: 457–72.
31.Goldberg, TE, Weinberger, DR, Berman, KF, Pliskin, NH, Podd, MH. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry 1987; 44: 1008–14.
32.Keefe, RS, Silva, SG, Perkins, DO, Lieberman, JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 1999; 25: 201–22.
33.Amminger, GP, Edwards, J, Brewer, WJ, Harrigan, S, McGorry, PD. Duration of untreated psychosis and cognitive deterioration in first episode schizophrenia. Schizophr Res 2002; 54: 223–30.
34.Barnes, TR, Hutton, SB, Chapman, MJ, Mutsatsa, S, Puri, BK, Joyce, EM. West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis. Br J Psychiatry 2000; 177: 207–11.
35.Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62(9): 975–83.